Home Cart 0 Sign in  

[ CAS No. 89-55-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 89-55-4
Chemical Structure| 89-55-4
Structure of 89-55-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 89-55-4 ]

Related Doc. of [ 89-55-4 ]

Alternatived Products of [ 89-55-4 ]

Product Details of [ 89-55-4 ]

CAS No. :89-55-4 MDL No. :MFCD00002455
Formula : C7H5BrO3 Boiling Point : -
Linear Structure Formula :- InChI Key :IEJOONSLOGAXNO-UHFFFAOYSA-N
M.W : 217.02 Pubchem ID :6972
Synonyms :

Calculated chemistry of [ 89-55-4 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 43.12
TPSA : 57.53 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.33 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.56
Log Po/w (XLOGP3) : 3.23
Log Po/w (WLOGP) : 1.85
Log Po/w (MLOGP) : 1.75
Log Po/w (SILICOS-IT) : 1.42
Consensus Log Po/w : 1.96

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -3.56
Solubility : 0.06 mg/ml ; 0.000277 mol/l
Class : Soluble
Log S (Ali) : -4.11
Solubility : 0.0168 mg/ml ; 0.0000774 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -2.06
Solubility : 1.91 mg/ml ; 0.00881 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.31

Safety of [ 89-55-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 89-55-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 89-55-4 ]
  • Downstream synthetic route of [ 89-55-4 ]

[ 89-55-4 ] Synthesis Path-Upstream   1~12

  • 1
  • [ 89-55-4 ]
  • [ 2316-64-5 ]
YieldReaction ConditionsOperation in experiment
60%
Stage #1: With lithium aluminium tetrahydride In tetrahydrofuran at 20℃; for 16 h;
Stage #2: With hydrogenchloride In tetrahydrofuran; water
Step 3
4-Bromo-2-(hydroxymethyl)phenol:
A solution of 5-bromo-2-hydroxybenzoic acid (21.7 g; 100 mmol; 1.00 equiv) in tetrahydrofuran (200 mL) was added to a suspension of lithium aluminum hydride (5.7 g; 150 mmol; 1.50 equiv) in tetrahydrofuran (100 mL).
The suspension was virgously stirred for about 16 hours at ambient temperature and then quenched by adding 3M hydrochloric acid (300 mL).
Following standard extractive workup with ethyl acetate, the crude residue was re-crystallized from ethyl acetate/hexane (1/10) to give the title product as gray solid (12.4 g; 60percent yield).
1H NMR (400 MHz, CDCl3) 6: 9.68 (s, 1H), 7.39 (s, 1H), 7.19 (dd, J=2.0, 2.0 Hz, 1H), 6.72 (d, J=8.4 Hz, 1H), 5.10 (s, 1H), 4.44 (s, 2H).
Reference: [1] Patent: US5587392, 1996, A,
[2] Patent: US2010/9950, 2010, A1, . Location in patent: Page/Page column 20
[3] Chemische Berichte, 1906, vol. 39, p. 2938
[4] Journal of Organic Chemistry, 2006, vol. 71, # 9, p. 3646 - 3649
  • 2
  • [ 89-55-4 ]
  • [ 98-80-6 ]
  • [ 323-87-5 ]
Reference: [1] Doklady Chemistry, 1990, vol. 315, # 4-6, p. 354 - 357[2] Dokl. Akad. Nauk SSSR Ser. Khim., 1990, vol. 315, # 5, p. 1133 - 1136
[3] Dalton Transactions, 2017, vol. 46, # 26, p. 8598 - 8610
[4] Chemistry - A European Journal, 2014, vol. 20, # 11, p. 3050 - 3060
[5] Organic and Biomolecular Chemistry, 2014, vol. 12, # 25, p. 4511 - 4516
[6] Journal of Medicinal Chemistry, 2009, vol. 52, # 21, p. 6539 - 6542
[7] Organic letters, 2001, vol. 3, # 8, p. 1177 - 1180
  • 3
  • [ 89-55-4 ]
  • [ 143-66-8 ]
  • [ 323-87-5 ]
Reference: [1] Tetrahedron, 1997, vol. 53, # 42, p. 14437 - 14450
[2] Russian Journal of General Chemistry, 1996, vol. 66, # 12, p. 1925 - 1938
[3] Tetrahedron Letters, 2005, vol. 46, # 24, p. 4255 - 4259
  • 4
  • [ 89-55-4 ]
  • [ 100-58-3 ]
  • [ 323-87-5 ]
Reference: [1] Journal of Organometallic Chemistry, 1997, vol. 532, # 1-2, p. 271 - 273
  • 5
  • [ 89-55-4 ]
  • [ 31044-59-4 ]
  • [ 323-87-5 ]
Reference: [1] Tetrahedron, 1997, vol. 53, # 42, p. 14437 - 14450
[2] Russian Journal of General Chemistry, 1996, vol. 66, # 12, p. 1925 - 1938
  • 6
  • [ 89-55-4 ]
  • [ 21739-92-4 ]
YieldReaction ConditionsOperation in experiment
92.1% With tetrachloromethane; molybdenum hexacarbonyl In dimethyl sulfoxide at 150℃; for 6 h; Autoclave This example is the preparation of 2-chloro-5-bromo-benzoic acid, and the specific method is as follows:2.14 g of molybdenum hexacarbonyl (0.01 mol) was added to a 1 L autoclave.217.0 g of 2-hydroxy-5-bromobenzoic acid (1.0 mol),185.0 g of carbon tetrachloride (1.2 mol) and 250 mL of dimethyl sulfoxide,Heat to 150 ° C,The reaction was stirred for 6 h.After the end of the controlled reaction in HPLC,Evaporate the solvent under reduced pressure.Then add 250 mL of acetonitrile,Warm up to 70 ° C and stir to dissolve.Then add neutral alumina for hot filtration.The filtrate was cooled to room temperature.A pale yellow solid precipitated.Then, 564 mL of an ethanol/water mixed solvent (volume ratio 1:3) was added.After heating and dissolving,Slowly cool to 60 ° C first,After a small amount of crystals are precipitated,Cooled to 50 ° C for 1 h,Finally, it was slowly cooled to 28 ° C and stirred for 3 h.filter,Collecting white solids,Washed twice in cold water and dried.217.0 g of white solid 2-chloro-5-bromo-benzoic acid were obtained.The yield was 92.1percent and the purity was 99.9percent (HPLC).
Reference: [1] Patent: CN108250060, 2018, A, . Location in patent: Paragraph 0016; 0059-0062
  • 7
  • [ 89-55-4 ]
  • [ 62176-31-2 ]
Reference: [1] Patent: WO2011/38572, 2011, A1,
[2] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 17, p. 4034 - 4038
[3] Bioorganic and Medicinal Chemistry Letters, 2019, vol. 29, # 2, p. 212 - 215
  • 8
  • [ 67-56-1 ]
  • [ 89-55-4 ]
  • [ 4068-76-2 ]
YieldReaction ConditionsOperation in experiment
89% at 0 - 70℃; for 40 h; Heating / reflux Intermediate III: 6- (aminomethyl)-2,2-dimethyl-4H-1,3-benzodioxin-4-one; Step a) Formation of methyl-5-bromosalicylate; To a solution of 5-BROMOSALICYLIC acid (200 G, 0.92 mol) in METHANE . (2 L) was added thionylchloride (440 g, 3.7 mol) at 0°C with stirring and then allowed to reflux at 70°C for 40H. Excess solvent was distilled off and to the crude residue was added EtOAc (2 L). The organic layer was washed with 10percent cold aqueous NAHC03 solution (2X1 L), brine and dried. The solvent was removed UNDER vacuum to give the title compound as a low melting point solid (190 g, 89percent). TLC: PetEther/EtOAc, 7:3, Rf: 0.6
89% at 0 - 70℃; for 40 h; Heating / reflux To a solution of 5-bromosalicylic acid (200 g, 0.92 mol) in methanol (2 L) was added thionylchloride (440 g, 3.7 mol) at 0°C with stirring and then allowed to reflux at 70°C for 40h. Excess solvent was distilled off and to the crude residue was added EtOAc (2 L). The organic layer was washed with 10percent cold aqueous NaHCO3 solution (2 x 1 L), brine and dried. The solvent was removed under vacuum to give the title compound as a low melting point solid (190 g, 89percent). TLC: PetEther/EtOAc, 7: 3, Rf: 0. 6
81% for 12 h; Reflux 5-Bromo-2-hydroxybenzoic acid (2.17 g, 10 mmol) was dissolved in methanol (50 ml_) and sulfuric acid (100percent, 1 ml_) and heated at rx for 12 h. After cooling and neutralization (NaHCO3, aq, sat), the white precipitate was filtered off and washed with water and dried, furnishing 1.92 g (81percent) of intermediate I.
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 10, p. 2621 - 2625
[2] Journal of Materials Chemistry, 1996, vol. 6, # 8, p. 1297 - 1307
[3] Organic Letters, 2014, vol. 16, # 19, p. 5140 - 5143
[4] Patent: WO2005/12280, 2005, A1, . Location in patent: Page/Page column 46-47
[5] Patent: WO2005/11685, 2005, A1, . Location in patent: Page/Page column 41
[6] Organic Letters, 2009, vol. 11, # 21, p. 4790 - 4793
[7] Journal of the American Chemical Society, 2001, vol. 123, # 43, p. 10429 - 10435
[8] Patent: WO2009/138758, 2009, A2, . Location in patent: Page/Page column 73
[9] Journal of Fluorine Chemistry, 1995, vol. 74, p. 69 - 76
[10] Gazzetta Chimica Italiana, 1886, vol. 16, p. 402
[11] Journal of Medicinal Chemistry, 1992, vol. 35, # 2, p. 310 - 319
[12] Synthetic Communications, 2000, vol. 30, # 4, p. 689 - 699
[13] Journal of Organic Chemistry, 2007, vol. 72, # 2, p. 583 - 588
[14] Angewandte Chemie, International Edition, 2009, vol. 48, # 23, p. 4226 - 4228
[15] Journal of Medicinal Chemistry, 2011, vol. 54, # 6, p. 1555 - 1564
[16] Medicinal Chemistry Research, 2014, vol. 23, # 7, p. 3274 - 3286
[17] Polyhedron, 2017, vol. 128, p. 18 - 29
[18] Journal of the American Chemical Society, 2018, vol. 140, # 9, p. 3412 - 3422
  • 9
  • [ 89-55-4 ]
  • [ 74-88-4 ]
  • [ 4068-76-2 ]
Reference: [1] Organic Letters, 2015, vol. 17, # 18, p. 4550 - 4553
[2] Organic Letters, 2018, vol. 20, # 5, p. 1316 - 1319
  • 10
  • [ 89-55-4 ]
  • [ 15459-51-5 ]
Reference: [1] Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1928, vol. 186, p. 1130
  • 11
  • [ 89-55-4 ]
  • [ 6329-74-4 ]
YieldReaction ConditionsOperation in experiment
82%
Stage #1: With sulfuric acid In butan-1-ol for 48 h; Heating / reflux
Stage #2: With ammonia In methanol at 20℃; for 48 h;
A. 5-bromo-2-hydroxybenzamide; 0 OH 0 OH 1. n-butanol, H2SO4, reflux HO X 2. NH3, MeOH H2N 82percent Br Br To a stirred solution of 5-Bromosalicyclic acid (30 g, 135.5 mmol) in n-butylalcohol (60 mL) was added H2SO4 (95.6percent, 289 L, 5.42 mmol) in a 100 ml round bottom flask connected by a Dean-Stark trap/reflux condenser that was filled with 12 ml of n-butylalcohol. After heated to reflux for 2 days, the reaction was cooled down to R. T. and concentrated to give a pale yellow oil. The mixture was added 50 mL MeOH, followed by NH3 in MeOH (7 N, 116 mL). The reaction was stirred at R. T. for another 2 days, monitored by HPLC. After the reaction complete, it was concentrated to give a white solid. The crude solid was washed with small amount of EtOAc and hexane to afford 24 g of the product as a white crystalline solid (82percent yield).
23%
Stage #1: at 80℃; for 4 h;
Stage #2: With ammonium hydroxide In tetrahydrofuran at 20℃; for 2 h;
A solution of 5-bromo-2-hydroxybenzoic acid (20 g, 92.16 mmol, 1.00 equiv) in thionyl chloride (50 mE) was stirred at 80° C. for 4 h. The mixture was concentrated under vacuum. Then the residue was added to a solution of ammonia (50 mE) in tetrahydrofuran (50 mE) and stirred at room temperature for 2 h. Ethyl acetate (50 mE) was added to the reaction. The solid was filtered out. The filtrate was concentrated under vacuum and purified by Si02 chromatography eluted with ethyl acetate/petroleum ether (1:5) to afford 4.5 g (23percent) of 5-bromo-2-hydroxybenzamide as a yellow solid. EC-MS: mlz=216 [M+H].
Reference: [1] Patent: WO2005/95326, 2005, A2, . Location in patent: Page/Page column 253
[2] Patent: US2018/64726, 2018, A1, . Location in patent: Paragraph 0360; 0361
[3] Chemical and Pharmaceutical Bulletin, 1996, vol. 44, # 4, p. 734 - 745
[4] Patent: US2006/14737, 2006, A1, . Location in patent: Page/Page column 25
  • 12
  • [ 89-55-4 ]
  • [ 1285515-21-0 ]
Reference: [1] Patent: WO2011/38572, 2011, A1,
[2] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 17, p. 4034 - 4038
[3] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 17, p. 4034 - 4038
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 89-55-4 ]

Aryls

Chemical Structure| 1666-28-0

[ 1666-28-0 ]

4-Bromo-2-hydroxybenzoic acid

Similarity: 0.98

Chemical Structure| 3147-55-5

[ 3147-55-5 ]

3,5-Dibromo-2-hydroxybenzoic acid

Similarity: 0.94

Chemical Structure| 22717-56-2

[ 22717-56-2 ]

Methyl 4-bromo-2-hydroxybenzoate

Similarity: 0.91

Chemical Structure| 2476-35-9

[ 2476-35-9 ]

5-Bromo-2-methoxybenzoic acid

Similarity: 0.91

Chemical Structure| 14348-38-0

[ 14348-38-0 ]

4-Bromo-3-hydroxybenzoic acid

Similarity: 0.90

Bromides

Chemical Structure| 1666-28-0

[ 1666-28-0 ]

4-Bromo-2-hydroxybenzoic acid

Similarity: 0.98

Chemical Structure| 3147-55-5

[ 3147-55-5 ]

3,5-Dibromo-2-hydroxybenzoic acid

Similarity: 0.94

Chemical Structure| 22717-56-2

[ 22717-56-2 ]

Methyl 4-bromo-2-hydroxybenzoate

Similarity: 0.91

Chemical Structure| 2476-35-9

[ 2476-35-9 ]

5-Bromo-2-methoxybenzoic acid

Similarity: 0.91

Chemical Structure| 14348-38-0

[ 14348-38-0 ]

4-Bromo-3-hydroxybenzoic acid

Similarity: 0.90

Carboxylic Acids

Chemical Structure| 1666-28-0

[ 1666-28-0 ]

4-Bromo-2-hydroxybenzoic acid

Similarity: 0.98

Chemical Structure| 3147-55-5

[ 3147-55-5 ]

3,5-Dibromo-2-hydroxybenzoic acid

Similarity: 0.94

Chemical Structure| 2476-35-9

[ 2476-35-9 ]

5-Bromo-2-methoxybenzoic acid

Similarity: 0.91

Chemical Structure| 14348-38-0

[ 14348-38-0 ]

4-Bromo-3-hydroxybenzoic acid

Similarity: 0.90

Chemical Structure| 26792-49-4

[ 26792-49-4 ]

3-Bromo-2,6-dihydroxybenzoic acid

Similarity: 0.89